Cargando…

Tweeting links to Cochrane Schizophrenia Group reviews: a randomised controlled trial

OBJECTIVE: To assess the effects of using health social media on web activity. DESIGN: Individually randomised controlled parallel group superiority trial. SETTING: Twitter and Weibo. PARTICIPANTS: 170 Cochrane Schizophrenia Group full reviews with an abstract and plain language summary web page. IN...

Descripción completa

Detalles Bibliográficos
Autores principales: Adams, C E, Jayaram, M, Bodart, A Y M, Sampson, S, Zhao, S, Montgomery, A A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4785321/
https://www.ncbi.nlm.nih.gov/pubmed/26956164
http://dx.doi.org/10.1136/bmjopen-2015-010509
_version_ 1782420387956523008
author Adams, C E
Jayaram, M
Bodart, A Y M
Sampson, S
Zhao, S
Montgomery, A A
author_facet Adams, C E
Jayaram, M
Bodart, A Y M
Sampson, S
Zhao, S
Montgomery, A A
author_sort Adams, C E
collection PubMed
description OBJECTIVE: To assess the effects of using health social media on web activity. DESIGN: Individually randomised controlled parallel group superiority trial. SETTING: Twitter and Weibo. PARTICIPANTS: 170 Cochrane Schizophrenia Group full reviews with an abstract and plain language summary web page. INTERVENTIONS: Three randomly ordered slightly different 140 character or less messages, each containing a short URL to the freely accessible summary page sent on specific times on one single day. This was compared with no messaging. OUTCOME: The primary outcome was web page visits at 1 week. Secondary outcomes were other metrics of web activity at 1 week. RESULTS: 85 reviews were randomised to each of the intervention and control arms. Google Analytics allowed 100% follow-up within 1 week of completion. Intervention and control reviews received a total of 1162 and 449 visits, respectively (IRR 2.7, 95% CI 2.2 to 3.3). Fewer intervention reviews had single page only visits (16% vs 31%, OR 0.41, 0.19 to 0.88) and users spent more time viewing intervention reviews (geometric mean 76 vs 31 s, ratio 2.5, 1.3 to 4.6). Other secondary metrics of web activity all showed strong evidence in favour of the intervention. CONCLUSIONS: Tweeting in this limited area of healthcare increases ‘product placement’ of evidence with the potential for that to influence care. TRIAL REGISTRATION NUMBER: ISRCTN84658943.
format Online
Article
Text
id pubmed-4785321
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-47853212016-03-14 Tweeting links to Cochrane Schizophrenia Group reviews: a randomised controlled trial Adams, C E Jayaram, M Bodart, A Y M Sampson, S Zhao, S Montgomery, A A BMJ Open Mental Health OBJECTIVE: To assess the effects of using health social media on web activity. DESIGN: Individually randomised controlled parallel group superiority trial. SETTING: Twitter and Weibo. PARTICIPANTS: 170 Cochrane Schizophrenia Group full reviews with an abstract and plain language summary web page. INTERVENTIONS: Three randomly ordered slightly different 140 character or less messages, each containing a short URL to the freely accessible summary page sent on specific times on one single day. This was compared with no messaging. OUTCOME: The primary outcome was web page visits at 1 week. Secondary outcomes were other metrics of web activity at 1 week. RESULTS: 85 reviews were randomised to each of the intervention and control arms. Google Analytics allowed 100% follow-up within 1 week of completion. Intervention and control reviews received a total of 1162 and 449 visits, respectively (IRR 2.7, 95% CI 2.2 to 3.3). Fewer intervention reviews had single page only visits (16% vs 31%, OR 0.41, 0.19 to 0.88) and users spent more time viewing intervention reviews (geometric mean 76 vs 31 s, ratio 2.5, 1.3 to 4.6). Other secondary metrics of web activity all showed strong evidence in favour of the intervention. CONCLUSIONS: Tweeting in this limited area of healthcare increases ‘product placement’ of evidence with the potential for that to influence care. TRIAL REGISTRATION NUMBER: ISRCTN84658943. BMJ Publishing Group 2016-03-08 /pmc/articles/PMC4785321/ /pubmed/26956164 http://dx.doi.org/10.1136/bmjopen-2015-010509 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
spellingShingle Mental Health
Adams, C E
Jayaram, M
Bodart, A Y M
Sampson, S
Zhao, S
Montgomery, A A
Tweeting links to Cochrane Schizophrenia Group reviews: a randomised controlled trial
title Tweeting links to Cochrane Schizophrenia Group reviews: a randomised controlled trial
title_full Tweeting links to Cochrane Schizophrenia Group reviews: a randomised controlled trial
title_fullStr Tweeting links to Cochrane Schizophrenia Group reviews: a randomised controlled trial
title_full_unstemmed Tweeting links to Cochrane Schizophrenia Group reviews: a randomised controlled trial
title_short Tweeting links to Cochrane Schizophrenia Group reviews: a randomised controlled trial
title_sort tweeting links to cochrane schizophrenia group reviews: a randomised controlled trial
topic Mental Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4785321/
https://www.ncbi.nlm.nih.gov/pubmed/26956164
http://dx.doi.org/10.1136/bmjopen-2015-010509
work_keys_str_mv AT adamsce tweetinglinkstocochraneschizophreniagroupreviewsarandomisedcontrolledtrial
AT jayaramm tweetinglinkstocochraneschizophreniagroupreviewsarandomisedcontrolledtrial
AT bodartaym tweetinglinkstocochraneschizophreniagroupreviewsarandomisedcontrolledtrial
AT sampsons tweetinglinkstocochraneschizophreniagroupreviewsarandomisedcontrolledtrial
AT zhaos tweetinglinkstocochraneschizophreniagroupreviewsarandomisedcontrolledtrial
AT montgomeryaa tweetinglinkstocochraneschizophreniagroupreviewsarandomisedcontrolledtrial